查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1829744

2025年全球微創青光眼手術（MIGS）設備市場報告

Minimally Invasive Glaucoma Surgery (MIGS) Devices Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，微創青光眼手術 (MIGS) 設備的市場規模呈指數級成長，從 2024 年的 7 億美元成長到 2025 年的 8.9 億美元，複合年成長率為 27.6%。預測期內的成長可歸因於人們預防失明意識的增強、醫療基礎設施投資的增加、患者對先進視力治療的認知度不斷提高、公眾對先進視力治療的認知度不斷提高以及政府舉措的不斷加強。

微創青光眼手術 (MIGS) 設備市場規模預計將在未來幾年呈指數級成長，到 2029 年將達到 22.9 億美元，複合年成長率為 26.5%。預測期內的成長歸因於青光眼等眼科疾病的盛行率不斷上升、老年人口不斷成長、醫療保健基礎設施不斷完善以及對更安全、更高效治療的需求日益成長。預測期內的主要趨勢包括 MIGS 設備的普及、技術進步、創新型微創青光眼手術設備的開發、先進植入式設備的開發以及眼科技術的進步。

微創青光眼手術 (MIGS) 設備是一種旨在降低青光眼患者眼壓的醫療設備，其採用的侵入性比傳統青光眼手術更小。 MIGS 旨在提供更安全、侵入性更低的青光眼手術選擇，減少併發症，縮短恢復時間，並改善患者預後。

MIGS 裝置的主要類型包括瓣膜、青光眼引流植入、青光眼管分流器和支架。青光眼引流植入，也稱為房水分流器或管分流器，是透過手術植入眼內用於治療青光眼的小型裝置。這些裝置可用於多種手術，包括青光眼手術合併白內障摘除術或單獨的青光眼手術，其目標區域包括海綿狀視網膜和脈絡膜上腔。它們透過直銷和零售等各種管道分銷，並由眼科診所和門診手術中心 (ASC) 等終端用戶使用。

2025年春季美國關稅的突然上調及其引發的貿易摩擦對醫療設備行業產生了重大影響，尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制漲價，製造商面臨利潤壓力。監管挑戰使情況更加複雜，因為由於關稅而更換供應商通常需要醫療設備重新認證，導致市場進入延遲。為此，企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

本研究報告是商業研究公司（The Business Research Company）新報告系列的一部分，該系列提供微創青光眼手術 (MIGS) 設備的市場統計數據，例如全球市場規模、區域佔有率、競爭對手的市場佔有率、詳細的微創青光眼手術 (MIGS) 設備細分市場、市場趨勢和商機，以及您在微創青光眼手術 (MIGS) 設備行業取得成功所需的數據。本微創青光眼手術 (MIGS) 設備研究報告對該行業的現狀和未來趨勢進行了詳細分析，為您提供所需的一切觀點。

我們預測未來五年該市場將成長26.5%，較先前預測略有下降1.6%。這一下降主要源於美國與其他國家之間關稅的影響，這些關稅導致以色列製造的微型支架供應鏈中斷，從而直接影響美國，可能延誤青光眼患者的治療方案，並增加眼科手術費用。由於互惠關稅以及貿易緊張局勢和限制措施升級對全球經濟和貿易的負面影響，其影響將更為廣泛。

預計未來眼科疾病盛行率的上升將推動微創青光眼手術 (MIGS) 設備的成長。眼科疾病涵蓋了影響眼睛和視力的多種疾病，由於生活方式的改變、環境因素和人口老化，其盛行率正在上升。 MIGS 設備是用於治療各種眼科疾病的創新工具，主要透過降低眼壓來預防或減緩青光眼的進展。例如，根據美國政府機構國家眼科研究所的數據，到 2030 年，約有 220 萬美國將失明或部分失明。因此，眼科疾病盛行率的上升正在推動 MIGS 設備市場的發展。

MIGS 設備市場的主要企業正專注於開發創新產品，例如支架注射系統，以滿足青光眼管理中尚未滿足的需求並改善患者的治療效果。支架注射系統是一種 MIGS 設備，它透過類似注射的程序將小型支架輸送並植入體內，使用常用於微創手術治療血管阻塞或狹窄等疾病的專用輸送機制。例如，2022 年 8 月，美國眼科醫療技術公司 Glaucos Corporation 的 iStent Infinite 小梁微旁路系統獲得了美國食品藥物管理局(FDA) 的 510(k) 許可。 iStent Infinite 是一種新型三支架注射系統，旨在為無法透過藥物或手術治療控制眼壓的原發性開放性青光眼(POAG) 患者提供全天候眼壓控制的基礎。

2024年7月，瑞士醫療設備製造商愛爾康以8,100萬美元收購了貝爾金視力公司（Belkin Vision）。此次策略性收購旨在推廣直接選擇性雷射小樑整形術（DSLT）作為青光眼的第一線治療方法，使其在全球普及。貝爾金視力公司是醫療設備製造商，專門研發和製造用於治療青光眼的雷射治療設備。

微創青光眼手術 (MIGS) 裝置市場的主要參與者包括 AbbVie Inc.、Novartis AG、Alcon Inc.、Bausch Health Companies Inc.、Bausch & Lomb Incorporated Inc.、Carl Zeiss Meditec AG、Santen Pharmaceutical Co. Ltd.、Johnson & Johnson Vision Care Inc.、Lume Surm. Therapeutix Inc.、Iridex Corporation、Ellex Medical Lasers Ltd.、New World Medical Inc.、MicroSurgical Technology Inc.、Nova Eye Medical Limited、Asico LLC、Ziemer Ophthalmic Systems AG、Transcend Medical、iSTAR Medical SA、Ivantis Group Inc.、Allergan 和 InnFocus Inc.。

2024年，北美是微創青光眼手術 (MIGS) 設備市場最大的地區。預計亞太地區將成為預測期內成長最快的地區。微創青光眼手術 (MIGS) 設備市場報告涵蓋亞太地區、西歐、中歐和東歐、北美、南美以及中東和非洲。

微創青光眼手術 (MIGS) 設備市場報告涵蓋的國家有澳洲、巴西、中國、法國、德國、印度、印尼、日本、俄羅斯、韓國、英國、英國、美國、義大利和西班牙。

微創青光眼手術 (MIGS) 設備市場由提供以管道為基礎的手術、內臟吻合術和小管成形術的營業單位所獲得的收益所構成。市場價值包括服務供應商銷售或包含在其服務產品中的相關產品的價值。 MIGS 設備市場還包括青光眼引流植入、青光眼管分流器和侵入性設備的銷售。此市場價值為“出廠價”，即商品製造商或生產商銷售給其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接銷售給最終客戶的商品價值。該市場中的商品價值也包括商品製造商銷售的相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球微創青光眼手術 (MIGS) 設備：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 最終用途產業分析
  • 全球微創青光眼手術（MIGS）設備市場：成長率分析
  • 全球微創青光眼手術 (MIGS) 設備市場表現：規模與成長，2019-2024 年
  • 全球微創青光眼手術 (MIGS) 設備市場預測：規模與成長，2024-2029 年，2034 年
  • 全球微創青光眼手術 (MIGS) 設備：總目標市場 (TAM)

第6章 市場細分

  • 全球微創青光眼手術 (MIGS) 設備市場（按產品、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 閥門
  • 青光眼引流植入
  • 青光眼管分流術
  • 支架
  • 其他產品
  • 全球微創青光眼手術 (MIGS) 設備市場（按手術方式、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 青光眼伴白內障
  • 孤立性青光眼
  • 全球微創青光眼手術 (MIGS) 設備市場：按產品、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 小梁網
  • 脈絡膜上腔
  • 其他科目
  • 全球微創青光眼手術 (MIGS) 設備市場（按分銷管道、績效及預測），2019-2024 年、2024-2029 年、2034 年
  • 直接競標
  • 零售
  • 全球微創青光眼手術 (MIGS) 設備市場（按最終用戶、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 眼科診所
  • 門診手術中心（ASCS）
  • 其他最終用戶
  • 全球微創青光眼手術 (MIGS) 設備市場：按瓣膜細分（按類型）、業績及預測，2019-2024 年、2024-2029 年、2034 年
  • 微型分流閥
  • 非穿透閥
  • 全球微創青光眼手術 (MIGS) 裝置市場：按青光眼引流植入細分（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 鞏膜引流植入
  • 結膜下引流植入
  • 全球微創青光眼手術 (MIGS) 設備市場：按青光眼管分流器細分（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • Ahmed 管分流術
  • 瓣膜管分流術
  • 全球微創青光眼手術 (MIGS) 設備市場：按支架細分（按類型）、業績及預測，2019-2024 年、2024-2029 年、2034 年
  • 眼內支架
  • 眼外支架
  • 全球微創青光眼手術 (MIGS) 設備市場：按產品類型、性能和預測細分，2019-2024 年、2024-2029 年、2034 年
  • 循環破壞裝置
  • 小梁旁路裝置

第7章 區域和國家分析

  • 全球微創青光眼手術 (MIGS) 設備市場：按地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球微創青光眼手術 (MIGS) 設備市場：國家、績效及預測（2019-2024 年、2024-2029 年、2034 年）

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章：西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章：俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 微創青光眼手術（MIGS）設備市場：競爭格局
  • 微創青光眼手術（MIGS）設備市場：公司簡介
    • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Novartis AG Overview, Products and Services, Strategy and Financial Analysis
    • Alcon Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Bausch Health Companies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Bausch & Lomb Incorporated Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Carl Zeiss Meditec AG
  • Santen Pharmaceutical Co. Ltd.
  • Johnson & Johnson Vision Care Inc.
  • Lumenis Ltd.
  • Staar Surgical Company
  • Glaukos Corporation
  • Sight Sciences Inc.
  • Ocular Therapeutix Inc.
  • Iridex Corporation
  • Ellex Medical Lasers Ltd.
  • New World Medical Inc
  • MicroSurgical Technology Inc.
  • Nova Eye Medical Limited
  • Asico LLC
  • Ziemer Ophthalmic Systems AG

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029年微創青光眼手術（MIGS）設備市場：提供新機會的國家
  • 2029年微創青光眼手術（MIGS）設備市場：細分市場帶來新機會
  • 微創青光眼手術（MIGS）設備市場2029年：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r30703u

Minimally invasive glaucoma surgery (MIGS) devices are medical tools designed to lower intraocular pressure (IOP) in glaucoma patients using less invasive techniques compared to traditional glaucoma surgeries. These devices aim to reduce complications, shorten recovery times, and improve patient outcomes by providing a safer, less invasive surgical option for managing glaucoma.

The main types of MIGS devices include valves, glaucoma drainage implants, glaucoma tube shunts, stents, and others. A glaucoma drainage implant, also known as an aqueous shunt or tube shunt, is a small device surgically placed in the eye to treat glaucoma. These devices are used in various surgeries, such as those for glaucoma combined with cataracts or stand-alone glaucoma procedures, targeting areas such as the trabecular meshwork and suprachoroidal space. They are distributed through various channels, including direct tender and retail sales, and are utilized by end users such as ophthalmology clinics and ambulatory surgery centers (ASCs).

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The minimally invasive glaucoma surgery (MIGS) devices market research report is one of a series of new reports from The Business Research Company that provides minimally invasive glaucoma surgery (MIGS) devices market statistics, including minimally invasive glaucoma surgery (MIGS) devices industry global market size, regional shares, competitors with a minimally invasive glaucoma surgery (MIGS) devices market share, detailed minimally invasive glaucoma surgery (MIGS) devices market segments, market trends and opportunities, and any further data you may need to thrive in the minimally invasive glaucoma surgery (MIGS) devices industry. This minimally invasive glaucoma surgery (MIGS) devices research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The minimally invasive glaucoma surgery (migs) devices market size has grown exponentially in recent years. It will grow from $0.7 billion in 2024 to $0.89 billion in 2025 at a compound annual growth rate (CAGR) of 27.6%. The growth in the historic period can be attributed to increased awareness for the prevention of blindness, increased investments in healthcare infrastructure, increased patient awareness surrounding advanced corrective vision treatments, rise in awareness surrounding advanced corrective vision treatments, increased government initiatives.

The minimally invasive glaucoma surgery (migs) devices market size is expected to see exponential growth in the next few years. It will grow to $2.29 billion in 2029 at a compound annual growth rate (CAGR) of 26.5%. The growth in the forecast period can be attributed to increasing prevalence of eye disorders like glaucoma, rise in geriatric population, growing healthcare infrastructure, growing need for safer and more efficient treatment. Major trends in the forecast period include adoption of MIGS devices, advancements in technology, development of innovative minimally invasive glaucoma surgery devices, development of advanced implantable devices, advances in ophthalmic technology.

The forecast of 26.5% growth over the next five years reflects a modest reduction of 1.6% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for micro-stents manufactured in Israel, potentially delaying treatment options for glaucoma patients and increasing ophthalmic surgery costs.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of eye disorders is anticipated to drive the growth of minimally invasive glaucoma surgery (MIGS) devices in the future. Eye disorders cover a wide range of conditions affecting the eyes and vision, with their prevalence rising due to lifestyle changes, environmental factors, and aging populations. MIGS devices are innovative tools used to manage various eye diseases, primarily by reducing intraocular pressure (IOP) to prevent or control the progression of glaucoma. For example, according to the National Eye Institute, a US-based government agency, approximately 2.2 million Americans will be blind or partially blind by 2030. Consequently, the growing prevalence of eye disorders is propelling the MIGS devices market.

Leading companies in the MIGS devices market are focused on developing innovative products, such as stent injectable systems, to address unmet needs in glaucoma management and enhance patient outcomes. A stent injectable system is a MIGS device that delivers and implants a small stent into the body through an injection-like procedure, typically using a specialized delivery mechanism commonly employed in minimally invasive surgeries to treat conditions such as blocked or narrowed blood vessels. For instance, in August 2022, Glaukos Corporation, a US-based ophthalmic medical technology company, received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the iStent Infinite Trabecular Micro-Bypass System. The iStent Infinite is a novel three-stent injectable system designed to provide foundational, 24/7 IOP control for patients with primary open-angle glaucoma (POAG) whose IOP remains uncontrolled despite prior medication and surgical therapy.

In July 2024, Alcon Inc., a Switzerland-based medical device company, acquired BELKIN Vision Inc. for $81 million. This strategic acquisition is intended to boost the global adoption of Direct Selective Laser Trabeculoplasty (DSLT) as a first-line treatment for glaucoma. BELKIN Vision Inc., an Israel-based medical device company, specializes in developing and manufacturing laser therapy devices for glaucoma treatment.

Major companies operating in the minimally invasive glaucoma surgery (MIGS) devices market are AbbVie Inc., Novartis AG, Alcon Inc., Bausch Health Companies Inc., Bausch & Lomb Incorporated Inc., Carl Zeiss Meditec AG, Santen Pharmaceutical Co. Ltd., Johnson & Johnson Vision Care Inc., Lumenis Ltd., Staar Surgical Company, Glaukos Corporation, Sight Sciences Inc., Ocular Therapeutix Inc., Iridex Corporation, Ellex Medical Lasers Ltd., New World Medical Inc, MicroSurgical Technology Inc., Nova Eye Medical Limited, Asico LLC, Ziemer Ophthalmic Systems AG, Transcend Medical, iSTAR Medical SA, Ivantis Group Inc., Allergan, InnFocus Inc.

North America was the largest region in the minimally invasive glaucoma surgery (MIGS) devices market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the minimally invasive glaucoma surgery (MIGS) devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the minimally invasive glaucoma surgery (MIGS) devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The minimally invasive glaucoma surgery (MIGS) devices market consists of revenues earned by entities by providing canal-based procedures, viscocanalostomy, and canaloplasty procedures. The market value includes the value of related goods sold by the service provider or included within the service offering. The minimally invasive glaucoma surgery (MIGS) devices market also includes sales of glaucoma drainage implants, glaucoma tube shunts, and invasive devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Minimally Invasive Glaucoma Surgery (MIGS) Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on minimally invasive glaucoma surgery (migs) devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for minimally invasive glaucoma surgery (migs) devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The minimally invasive glaucoma surgery (migs) devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Valves; Glaucoma Drainage Implant; Glaucoma Tube Shunts; Stents; Other Products
  • 2) By Surgery: Glaucoma In Conjunction With Cataract; Stand Alone Glaucoma
  • 3) By Target: Trabecular Meshwork; Suprachoroidal Space; Other Targets
  • 4) By Distribution Channel: Direct Tender; Retail Sales
  • 5) By End User: Ophthalmology Clinics; Ambulatory Surgery Centers (ASCS); Other End Users
  • Subsegments:
  • 1) By Valves: Micro Shunt Valves; Non-penetrating Valves
  • 2) By Glaucoma Drainage Implant: Scleral Drainage Implants; Subconjunctival Drainage Implants
  • 3) By Glaucoma Tube Shunts: Ahmed Tube Shunt; Baerveldt Tube Shunt
  • 4) By Stents: Ab-Interno Stents; Ab-Externo Stents
  • 5) By Other Products: Cyclodestructive Devices; Trabecular Bypass Devices
  • Companies Mentioned: AbbVie Inc.; Novartis AG; Alcon Inc.; Bausch Health Companies Inc.; Bausch & Lomb Incorporated Inc.; Carl Zeiss Meditec AG; Santen Pharmaceutical Co. Ltd.; Johnson & Johnson Vision Care Inc.; Lumenis Ltd.; Staar Surgical Company; Glaukos Corporation; Sight Sciences Inc.; Ocular Therapeutix Inc.; Iridex Corporation; Ellex Medical Lasers Ltd.; New World Medical Inc; MicroSurgical Technology Inc.; Nova Eye Medical Limited; Asico LLC; Ziemer Ophthalmic Systems AG; Transcend Medical; iSTAR Medical SA; Ivantis Group Inc.; Allergan; InnFocus Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Characteristics

3. Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Trends And Strategies

4. Minimally Invasive Glaucoma Surgery (MIGS) Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Growth Rate Analysis
  • 5.4. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Total Addressable Market (TAM)

6. Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Segmentation

  • 6.1. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Valves
  • Glaucoma Drainage Implant
  • Glaucoma Tube Shunts
  • Stents
  • Other Products
  • 6.2. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Surgery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Glaucoma In Conjunction With Cataract
  • Stand Alone Glaucoma
  • 6.3. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Trabecular Meshwork
  • Suprachoroidal Space
  • Other Targets
  • 6.4. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Direct Tender
  • Retail Sales
  • 6.5. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Ophthalmology Clinics
  • Ambulatory Surgery Centers (ASCS)
  • Other End Users
  • 6.6. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Sub-Segmentation Of Valves, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Micro Shunt Valves
  • Non-penetrating Valves
  • 6.7. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Sub-Segmentation Of Glaucoma Drainage Implant, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Scleral Drainage Implants
  • Subconjunctival Drainage Implants
  • 6.8. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Sub-Segmentation Of Glaucoma Tube Shunts, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Ahmed Tube Shunt
  • Baerveldt Tube Shunt
  • 6.9. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Sub-Segmentation Of Stents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Ab-Interno Stents
  • Ab-Externo Stents
  • 6.10. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cyclodestructive Devices
  • Trabecular Bypass Devices

7. Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Regional And Country Analysis

  • 7.1. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices Market

  • 8.1. Asia-Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Surgery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Minimally Invasive Glaucoma Surgery (MIGS) Devices Market

  • 9.1. China Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Overview
  • 9.2. China Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Surgery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Minimally Invasive Glaucoma Surgery (MIGS) Devices Market

  • 10.1. India Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Surgery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Minimally Invasive Glaucoma Surgery (MIGS) Devices Market

  • 11.1. Japan Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Overview
  • 11.2. Japan Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Surgery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Minimally Invasive Glaucoma Surgery (MIGS) Devices Market

  • 12.1. Australia Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Surgery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Minimally Invasive Glaucoma Surgery (MIGS) Devices Market

  • 13.1. Indonesia Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Surgery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Minimally Invasive Glaucoma Surgery (MIGS) Devices Market

  • 14.1. South Korea Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Overview
  • 14.2. South Korea Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Surgery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Market

  • 15.1. Western Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Overview
  • 15.2. Western Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Surgery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Minimally Invasive Glaucoma Surgery (MIGS) Devices Market

  • 16.1. UK Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Surgery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Minimally Invasive Glaucoma Surgery (MIGS) Devices Market

  • 17.1. Germany Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Surgery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Minimally Invasive Glaucoma Surgery (MIGS) Devices Market

  • 18.1. France Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Surgery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Minimally Invasive Glaucoma Surgery (MIGS) Devices Market

  • 19.1. Italy Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Surgery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Minimally Invasive Glaucoma Surgery (MIGS) Devices Market

  • 20.1. Spain Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Surgery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Market

  • 21.1. Eastern Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Overview
  • 21.2. Eastern Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Surgery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Minimally Invasive Glaucoma Surgery (MIGS) Devices Market

  • 22.1. Russia Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Surgery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market

  • 23.1. North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Overview
  • 23.2. North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Surgery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Minimally Invasive Glaucoma Surgery (MIGS) Devices Market

  • 24.1. USA Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Overview
  • 24.2. USA Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Surgery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Minimally Invasive Glaucoma Surgery (MIGS) Devices Market

  • 25.1. Canada Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Overview
  • 25.2. Canada Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Surgery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market

  • 26.1. South America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Overview
  • 26.2. South America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Surgery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Minimally Invasive Glaucoma Surgery (MIGS) Devices Market

  • 27.1. Brazil Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Surgery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Minimally Invasive Glaucoma Surgery (MIGS) Devices Market

  • 28.1. Middle East Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Overview
  • 28.2. Middle East Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Surgery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Minimally Invasive Glaucoma Surgery (MIGS) Devices Market

  • 29.1. Africa Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Overview
  • 29.2. Africa Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Surgery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Competitive Landscape And Company Profiles

  • 30.1. Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Competitive Landscape
  • 30.2. Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Company Profiles
    • 30.2.1. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Alcon Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Bausch Health Companies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Bausch & Lomb Incorporated Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Other Major And Innovative Companies

  • 31.1. Carl Zeiss Meditec AG
  • 31.2. Santen Pharmaceutical Co. Ltd.
  • 31.3. Johnson & Johnson Vision Care Inc.
  • 31.4. Lumenis Ltd.
  • 31.5. Staar Surgical Company
  • 31.6. Glaukos Corporation
  • 31.7. Sight Sciences Inc.
  • 31.8. Ocular Therapeutix Inc.
  • 31.9. Iridex Corporation
  • 31.10. Ellex Medical Lasers Ltd.
  • 31.11. New World Medical Inc
  • 31.12. MicroSurgical Technology Inc.
  • 31.13. Nova Eye Medical Limited
  • 31.14. Asico LLC
  • 31.15. Ziemer Ophthalmic Systems AG

32. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Minimally Invasive Glaucoma Surgery (MIGS) Devices Market

34. Recent Developments In The Minimally Invasive Glaucoma Surgery (MIGS) Devices Market

35. Minimally Invasive Glaucoma Surgery (MIGS) Devices Market High Potential Countries, Segments and Strategies

  • 35.1 Minimally Invasive Glaucoma Surgery (MIGS) Devices Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Minimally Invasive Glaucoma Surgery (MIGS) Devices Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Minimally Invasive Glaucoma Surgery (MIGS) Devices Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer